STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho KL, Levine A, Croft NM, Bronsky J, Shouval DS, Assa A, Harris R, Kiparissi F, Aloi M, Afzal NA, Tzivinikos C, Barrio J, Norden C, Vega MJB, Buderus S, de Valderrama AF, de Ridder L, García-Romero R, Medina E, Sánchez C, Velasco M, Vicente S, Wilson DC, Naik S, Hradsky O, Cococcioni L, Martin-de-Carpi J.
Pujol-Muncunill G, et al.
Eur J Pediatr. 2024 May 3. doi: 10.1007/s00431-024-05588-2. Online ahead of print.
Eur J Pediatr. 2024.
PMID: 38700692
What is Known: Ustekinumab is an effective therapy for adult moderate to severe Crohn's disease (CD). Off-label use of ustekinumab in children is increasing especially in anti-TNF refractory CD. ...
What is Known: Ustekinumab is an effective therapy for adult moderate to severe Crohn's disease (CD). Off-label use of ustekinumab in …